Details on Transfer Payment Programs

Table of Contents

• Transfer payment programs with total planned spending of $5 million or more
  • Canada Brain Research Fund Program
  • Canadian Thalidomide Survivors Support Program
  • Contribution to Canada Health Infoway
  • Contribution to Improve Health Care Quality and Patient Safety
  • Contribution to the Canadian Agency for Drugs and Technologies in Health
  • Contribution to the Canadian Institute for Health Information
  • Contribution to the Canadian Partnership Against Cancer
  • Health Care Policy and Strategies Program
  • Improving Affordable Access to Prescription Drugs Program
  • Mental Health Commission of Canada Contribution Program
  • National Strategy for Drugs for Rare Diseases Program
  • Official Languages Health Program
  • Oral Health Access Fund
  • Organs, Tissues, and Blood Program
  • The Shared Health Priorities Initiative
  • Substance Use and Addictions Program
  • Territorial Health Investment Fund
• Transfer payment programs with total planned spending of less than $5 million
  • Chemicals Management Plan Engagement and Outreach Contribution Program
  • Climate Change and Health Capacity Building Program
  • Environmental Health Research Contribution Program
  • Radon Outreach Contribution Program

Transfer payment programs with total planned spending of $5 million or more

Canada Brain Research Fund Program

Start date

April 1, 2011

End date

March 31, 2026

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care systems

Link to the department's Program inventory

Program 3: Quality Health Science, Data and Evidence

Purpose and objectives of transfer payment program

In Budgets 2011, 2016, and 2019, and through a subsequent funding commitment in 2021, the Government of Canada provided a cumulative $200 million in matched funding with non-federal government donors, for the Canada Brain Research Fund Program "to support the very best Canadian neuroscience" and "to help the medical community better understand the brain and brain health." The Program provides funding for the Brain Canada Foundation (Brain Canada) which fundraises to match the federal contribution with donations from its private and charitable-sector donors and partners and then allocates grants to researchers across Canada. The Program's objectives are: 1) to serve as a focal point for private investment in brain research by attracting private and charitable donations to match federal funding; and 2) to support research that advances knowledge of the brain through grants to researchers.

Expected results

Funding for brain research is expected to lead to discoveries that will inform the development of prevention, diagnostic, therapeutic, clinical, technological, and health system solutions for brain diseases/disorders. Ultimately, these advances are expected to improve the health and quality of life of Canadians who are at risk of, or affected by brain diseases/disorders. To contribute to this outcome, the recipient organization (Brain Canada), in partnership with individual and corporate donors and private organizations, funds merit-based research awards across Canada. Team awards bring together scientists from different disciplines to advance science on the brain and brain diseases/disorders, while platform awards promote efficient sharing and access to equipment, expertise and/or data across research networks. Capacity building awards are dedicated to building the next generation of Canadian brain researchers through salary support and training; and knowledge translation, exchange and mobilization awards support the mobilization of knowledge generated from research to create evidence-based tools and resources. These investments align with Health Canada's mandate to strengthen the health care system, ensuring that it can: adapt to new challenges posed by the evolving needs of an aging population; harness advances in health technology; and ease the long-term care burden among the diverse population groups affected by neurological conditions.

In 2024-25, Brain Canada will continue to focus on research themes such as brain health, neurodegeneration, and mental health. To strengthen its impact, Brain Canada will grow its internal expertise in stakeholder engagement and expand its investment in knowledge mobilization. The latter will be achieved through targeted research awards, developing accessible content for brain health stakeholders, and establishing more diverse review panels. Brain Canada will support equity, diversity and inclusion in its organizational policies and activities, including research selection processes and funding initiatives seeking to improve health outcomes for diverse groups.

Fiscal year of last completed evaluation

2021-22

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

Not applicable.

General targeted recipient groups

The sole target recipient is the national non-profit organization Brain Canada, which acts as a third-party organization that raises and disburses funds for brain research. Brain Canada allocates awards to researchers across Canada targeting research institutes, hospitals, and health charities.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with Brain Canada staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Canadian Thalidomide Survivors Support Program

Start date

March 21, 2019

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2018-19

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 2: Healthy People and Communities

Purpose and objectives of transfer payment program

The Program objectives are to ensure that, for the remainder of their lives, eligible thalidomide survivors:

• Receive ongoing tax-free payments based on their level of disability.
• Have transparent and timely access to the Extraordinary Medical Assistance Fund.

Expected results

Expected results are that thalidomide survivors will access care, treatment and/or support which in turn will contribute to their aging with dignity.

In 2024-25, the third-party administrator will continue to engage directly with recognized thalidomide survivors through an annual survey. Based on survivor feedback and regular meetings with the Thalidomide Victims Association of Canada, the administrator will enhance processes related to the Extraordinary Medical Assistance Fund to reduce burden on survivors and increase access to available supports to help meet survivors' needs as they age.

Fiscal year of last completed evaluation

2019-20

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2024-25

General targeted recipient groups

Canadian not-for-profit and for-profit organizations are eligible for funding. Until 2025-26, the sole targeted recipient is Epig Class Action Services Canada Ltd.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with Epig Class Action Services Canada Ltd., a third-party administrator of the Canadian Thalidomide Survivors Support Program, to discuss the Program progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Contribution to Canada Health Infoway

Start date

April 1, 2016

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2023-24

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

Canada Health Infoway (Infoway) is an independent, not-for-profit corporation that is federally funded to work with jurisdictions and other stakeholders to support the development and adoption of digital health technologies across Canada. Between 2001 and 2010, the Government of Canada invested $2.1 billion in Infoway, through grants or up-front multi-year funding, to focus on electronic health records, and other priorities in digital health. In 2016, Infoway received an additional $50 million over 2 years via a contribution agreement to support short-term digital health activities in e-prescribing and telehomecare. This was followed by an additional contribution agreement in 2017 for $300 million over 5 years to expand e-prescribing and virtual care initiatives, support the continued adoption and use of electronic medical records, help patients to access their own health records electronically, and better link electronic health record systems to improve access by all providers and institutions. Budget 2019 further provided $36.5 million over 5 years with $5 million per year ongoing, for Infoway and the Canadian Institute for Health Information to support the creation of a pan-Canadian data and performance reporting system for Organ Donation and Transplantation. In 2020, Infoway was allocated $50 million over 2 years via a contribution agreement to support provinces, territories, and others to expand virtual health services to Canadians. In 2023, Infoway was allocated $211 million over 3 years under the Working Together to Improve Health Care for Canadians Plan confirmed in Budget 2023 to advance interoperability and e-prescribing in Canada.

In January 2022, federal, provincial, and territorial governments endorsed a digital health action plan. This included tasking Canada Health Infoway, the Canadian Institute for Health Information and Statistics Canada to advance pan-Canadian standards to ensure health data can securely flow across the health care system while protecting the privacy of Canadians. To advance this, Infoway co-developed a Shared Pan-Canadian Interoperability Roadmap to guide the shared objectives of a more connected health care system through standardized health data and digital tools.

In October 2023, all Health Ministers (except Québec) reiterated their commitment to advancing and adopting common interoperability standards as part of a Joint FPT Action Plan on Health Data and Digital Health including the implementation of the Interoperability Roadmap led by Infoway.

Expected results

Infoway will be expected to collaborate with provincial and territorial governments and stakeholders to contribute towards advancing interoperability and expanding digital health technologies, and engaging on, creating, and facilitating adoption of standards to support common approaches. Over time, this work is expected to lead to: health care providers being able to use digital health technologies to provide more efficient and high-quality health care; increase access and exchange of electronic health information; and enable Canadians to access their own data and use digital health technologies to manage and/or improve their health. The Program will ultimately lead to a more modern and sustainable health care system where Canadians have access to appropriate and effective health care.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2027-28

General targeted recipient groups

Infoway is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with Infoway staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Contribution to Improve Health Care Quality and Patient Safety

Start date

March 31, 2021

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2020-21

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care systems

Link to the department's Program inventory

Program 2: Healthy People and Communities

Purpose and objectives of transfer payment program

The Healthcare Excellence Canada (HEC) is an independent, not-for-profit agency funded primarily by Health Canada to provide improvement in health care quality and patient safety.

This contribution agreement supports the federal government's interest in achieving an accessible, high-quality, sustainable, and accountable health system adaptable to the needs of Canadians. HEC accomplishes this by finding and promoting innovators and innovations; driving rapid adoption and spreading quality and safety innovations; and building capacities to enable excellence in healthcare and catalyze policy change.

Expected results

In the short-term, HEC's work will contribute to spreading promising innovations, sustaining meaningful relationships with people HEC works with, and assisting in preparing health leaders to lead improvement efforts. In the medium-term, HEC's work will contribute to assisting the settings represented by the intermediaries HEC reaches (e.g., long-term care facilities, primary care facilities) in employing evidence-informed practices; and implementing policy changes to catalyze health quality and patient safety improvement and developing cultures conducive to improvement. Ultimately, HEC's work will contribute to sustaining, spreading, and scaling improvements as well as assisting health care settings in providing high-quality, safe, patient-orientated, and culturally safe care. In 2024-25, HEC will further expand its efforts on 3 key priorities: re-imagining care with – and for – older adults with health and social needs; providing care closer to home and community with safe transitions; and contributing to pandemic recovery and health system resilience, specifically through efforts to improve the retention and well-being of healthcare workers.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Healthcare Excellence Canada is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with HEC staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Contribution to the Canadian Agency for Drugs and Technologies in Health

Start date

April 1, 2008

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2022-23

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care systems

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit agency funded by Canadian federal, provincial, and territorial governments to provide credible, impartial and evidence-based information about the clinical/cost-effectiveness and optimal use of drugs and other health technologies to Canadian health care decision-makers.

The contribution agreement provides financial support for CADTH's core business activities, namely, Common Drug Review, pan-Canadian Oncology Drug Review, Health Technology Assessments and Optimal Use Projects. Through these activities, CADTH can create and disseminate evidence-based information about the effectiveness and cost of drugs and non-drug technologies. Provinces and territories use this information to help decide whether public health plans should include the particular health products in question.

Expected results

In addition to CADTH's delivery of credible, objective evidence products and services to support value-based management of health technologies in Canada's health care systems, further funding was provided to CADTH starting in 2023-24 to support the implementation of the National Strategy for Drugs and Rare Diseases. The funding is expected to improve the collection and use of real-world evidence, including patient registries, and the safety and effectiveness of information available to decision-makers and clinicians on drugs for rare diseases.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Canadian Agency for Drugs and Technologies in Health, an independent, not-for-profit agency is the sole recipient of transfer payment funds.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with CADTH staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Contribution to the Canadian Institute for Health Information

Start date

April 1, 1999

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2017-18

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 3: Quality Health Science, Data and Evidence

Purpose and objectives of transfer payment program

The Canadian Institute for Health Information (CIHI) is an independent, not-for-profit organization supported by federal, provincial, and territorial governments that provides essential data and analysis on Canada's health system and the health of Canadians. CIHI was created in 1994 by the federal, provincial, and territorial Ministers of Health to address significant gaps in health information. The organization provides comparable and actionable data and information that are used to accelerate improvements in health care, health system performance and population health across Canada. CIHI's broad range of health system databases, measurements, and standards, together with its evidence-based reports and analyses, are widely used by stakeholders in their decision-making processes. Further, CIHI protects the privacy of Canadians by ensuring the confidentiality and integrity of its health care information.

Between 1994 and 2018, the Government of Canada allocated approximately $1.232 billion in total to CIHI through a series of contribution agreements. Over the past 7 years (2017-18 to 2023-24), CIHI received $672.5 million, including new and ongoing funding for initiatives, such as:

• $3.7 million in March 2023 to advance pharmaceutical data activities in support of the Budget 2019 - Canadian Drug Agency Transition Office.
• $1.7 million in March 2023 to implement new priority data activities under the Budget 2019 - Drugs for Rare Diseases Strategy.
• $1.2 million in March 2023 in support of the Public Health Agency of Canada's Data Pathways for Public Health pilot project.
• $4.7 million in March 2023 to improve the organ donation and transplantation data and reporting system in Canada.
• $11.0 million in August 2023 to develop and report on new shared health priority data indicators with provinces, territories, and partners, including aging with dignity indicators; to begin establishing Health Workforce Canada and CIHI's health human resources support function; and to advance primary care data standards in support of the interoperability roadmap (in collaboration with Infoway). This is part of a $100 million over 5 years allocation to CIHI under the Working Together to Improve Health Care for Canadians Plan, confirmed in Budget 2023.

Expected results

In 2024-25, CIHI will continue to address data gaps in priority areas, including primary care, home and community care, long-term care, mental health care and addictions, hospital and emergency room capacity (including surgical backlogs), pharmaceuticals, and virtual care.

As part of the commitments under the Working Together to Improve Healthcare for Canadians Plan, CIHI will work with provinces and territories on developing new health system indicators, advancing work related to the implementation of Health Workforce Canada which will address gaps in health workforce data, and continue collaborating with Infoway on advancing primary care data standards in support of the interoperability roadmap. This will help to increase the comparability of these indicators, allowing for better reporting on the performance and delivery of health care across Canada, and for international comparisons. CIHI will produce annual reports, refine existing indicators, and develop new indicators as required. This work builds on CIHI's release of its first Snapshot Report, which was released in August 2023. Further, CIHI will work with provinces, territories, and data partners to ensure that future data sources can be disaggregated to allow for results to be presented according to priority populations including Indigenous Peoples.

Funding allows CIHI to provide essential information on Canada's health care systems. CIHI's data is used to accelerate improvements in health care, health system performance and population health across the continuum of care. CIHI's stakeholders use the broad range of the Institute's health system databases, measurements, and standards, together with their evidence-based reports and analyses, in their decision-making processes. CIHI protects the privacy of Canadians by ensuring the confidentiality and integrity of the health care information provided.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2027-28

General targeted recipient groups

CIHI is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with CIHI staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Contribution to the Canadian Partnership Against Cancer

Start date

April 1, 2007

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2020-21

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care system
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

The Canadian Partnership Against Cancer (CPAC) is an arm's-length, not-for-profit organization that was established in 2007 by the Government of Canada. CPAC's mandate is to mobilize partners across the country to reduce the burden of cancer through coordinated, system-level change through the implementation of the Canadian Strategy for Cancer Control (the Strategy).

The Strategy is an overarching framework for a comprehensive Canadian cancer control program. The work of the Strategy spans the spectrum of cancer control, from research, prevention and detection to treatment, survivorship, and end-of-life care.

Developed in consultation with Canadians, including cancer experts and stakeholders, the Strategy's objectives include:

• Reducing the expected number of new cases of cancer among Canadians.
• Enhancing the quality of life of people living with cancer.
• Lessening the likelihood of Canadians dying from cancer.

CPAC is funded in 5-year terms with its current contribution agreement ending on March 31, 2027.

Expected results

CPAC continues to work collaboratively with stakeholders to accelerate the uptake of evidence across the cancer control continuum to improve both practice and policy to lessen the burden of cancer. A coordinated, knowledge-centered approach to cancer control is expected to reduce the economic burden of cancer, alleviate pressures on the health system, and consolidate information for all Canadians.

CPAC will enhance cancer control through knowledge management and the coordination of efforts among the provinces and territories, cancer experts, stakeholder groups, and Indigenous organizations to champion change, improve health outcomes related to cancer, and leverage existing investments.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2027-28

General targeted recipient groups

Canadian Partnership Against Cancer is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with CPAC staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Health Care Policy and Strategies Program

Start date

September 24, 2002

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canadians have modern and sustainable health care systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

• Program 1: Responsive Health Care Systems
• Program 2: Healthy People and Communities
• Program 3: Quality Health Science, Data and Evidence

Purpose and objectives of transfer payment program

The Health Care Policy and Strategies Program provides time-limited contribution funding for projects that address specific health care systems priorities, including mental health care, home and community care, palliative and end-of-life care, and other federal, provincial, territorial, and emerging priorities. Through the implementation of contribution agreements and a variety of stakeholder engagement activities, Health Canada contributes to the development and application of effective approaches to support sustainable improvements to health care systems. The Program's authorities also support initiatives related to the Terry Fox Research Initiative, Sexual Reproductive Health Fund and Medical Assistance in Dying policy and practice, and the implementation of the Department's Action Plan on Palliative Care.

Expected results

Program funding will support a wide range of projects designed to ultimately contribute to improvements in the accessibility, quality, sustainability, and accountability of the health care system. These improvements could ultimately benefit either specific populations, or all Canadians. For example, projects that produce and transfer knowledge in key areas will help improve Canada's health care systems and advance health policy. Other projects will identify, develop, implement, assess, and promote new or modified tools, approaches and best practices that respond to identified health care system priorities and promote people-centered health care. Another range of projects will identify, develop, implement, assess, and promote training, skills development, standards, products and technological solutions that will help modernize health care systems delivery.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2027-28

General targeted recipient groups

Non-profit non-governmental organizations, and other levels of government (provincial, territorial, and local).

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with staff and senior management of the various recipient groups to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreements, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Improving Affordable Access to Prescription Drugs Program

Start date

August 11, 2021

End date

March 31, 2025

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

The purpose of this agreement is to expand Prince Edward Island's (PEI) public formulary and improve the affordability of its public drug plans to levels more comparable to other provinces and territories. This partnership between the Government of Canada and PEI is aimed at increasing access for PEI residents to a wider range of prescription medications while also reducing their out-of-pocket costs.

Insights and lessons learned from this contribution agreement may be used to inform the future implementation of national pharmacare.

Expected results

This Program is expected to result in more affordable access to prescription drugs for PEI residents. This includes expanded access to medications covered by PEI's public drug plans (PEI formulary) and reduced out-of-pocket costs for these medications. For example, PEI has reduced co-pays to $5 for certain common medications. In the long-term, the Program will result in improved alignment across provinces and territories public drug plans and increase the knowledge to inform future decisions by all levels of government on the implementation of national pharmacare.

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

Not applicable.

General targeted recipient groups

Government of Prince Edward Island

Initiatives to engage applicants and recipients

Health Canada officials continue to undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with the responsible PEI staff and senior management to discuss progress. In addition, Health Canada continues to monitor the recipient's compliance with the funding agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Mental Health Commission of Canada Contribution Program

Start date

April 1, 2017

End date

March 31, 2027

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 2: Healthy People and Communities

Purpose and objectives of transfer payment program

The Mental Health Commission of Canada (MHCC), an arm's length, not-for-profit organization, was established in March 2007 with a 10-year mandate to improve health and social outcomes for people and their families living with mental illness. Between 2007 and 2017, the Government of Canada invested $130 million in the MHCC through a grant, to develop a mental health strategy for Canada, conduct an anti-stigma campaign, and create a knowledge exchange centre. In 2016, the MHCC's mandate was renewed for a 10-year period, from 2017-18 to 2026-27, to advance work on mental health priorities in 4 areas: the integration of mental health and substance use (in collaboration with the Canadian Centre on Substance Use and Addictions), suicide prevention, priority populations, and engagement with diverse stakeholders.

Expected results

The MHCC is expected to contribute to the improved mental health and well-being of Canadians, notably in the areas of suicide prevention, stigma reduction, population-based initiatives, and mental health and substance use integration. This will be done through developing and disseminating knowledge products, establishing collaborative partnerships, and providing evidence-based trainings.

A variety of learning materials (online modules, training, videos, etc.) will be targeted for children and youth, older adults, Indigenous communities, and underserved and marginalized populations. In addition, the MHCC will further support the implementation of the National Standard for Psychological Health and Safety in the Workplace and the National Standard for Mental Health and Well-Being of Post-Secondary Students.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2028-29

General targeted recipient groups

The Mental Health Commission of Canada is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with MHCC staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

National Strategy for Drugs for Rare Diseases Program

Start date

December 13, 2022

End date

March 31, 2026

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2022-23

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Healthcare Systems

Purpose and objectives of transfer payment program

The purpose of the Program is to achieve better health outcomes for patients with rare diseases by providing funding to willing jurisdictions to improve access to drugs for rare diseases (DRD), broadening rare disease treatments and services, and building national DRD governance and data infrastructure elements. The objectives of the Program are to seek national consistency, support patient outcomes and system sustainability, collect and use evidence, and invest in innovation.

Expected results

Expected results include improved collaboration across public drug plans for national consistency in patient access to DRD. Over time, this work is expected to lead to Canadians with rare diseases having nationally consistent access to more affordable drugs together with better data and information on DRD and health services related to rare diseases. The Program will ultimately lead to Canadians with rare diseases and their families having improved health and access to health care.

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Provincial and Territorial Governments

Initiatives to engage applicants and recipients

Provinces and territories will be engaged through bilateral funding agreements as well as other aspects of the National Strategy, including national governance and data infrastructure components. Health Canada will monitor the recipients' compliance with the funding agreements, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Official Languages Health Program

Start date

June 18, 2003

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2023-24

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 2: Healthy People and Communities

Purpose and objectives of transfer payment program

The Official Languages Health Program has a total budget of $206.7 million over 5 years (2023-28), $40.4 million in 2023-24 and $41.66 million per year from 2024-25 to 2027-28, including $5.2 million in operating costs (2023-28). The Program supports the federal government's commitment to maintain a strong and effective publicly funded health care system by ensuring that official language minority communities (OLMCs) have access to health services in the official language of their choice. Through the implementation of contribution agreements, Health Canada supports investments that improve the active offer of health services for OLMCs, through training and retention of health care providers, networking activities and innovative projects that increase access to health services for OLMCs.

Expected results

Program funding will support training and retention of health professionals, health networking and innovative projects to improve access to health services for OLMCs. These activities are expected to increase access to bilingual health professionals in OLMCs, and to increase the active offer of health services in the minority official language to address the health needs of OLMCs.

Fiscal year of last completed evaluation

2022-23

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Eligible recipients under the program are non-profit entities, provincially-accredited postsecondary institutions, and provincial and territorial government bodies.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with recipients to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Oral Health Access Fund

Start date

2025-26

End date

Ongoing

Type of transfer payment

Grants

Contributions

Type of appropriation

Estimates

Fiscal year for terms and conditions

2023-24

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 2: Healthy People and Communities

Purpose and objectives of transfer payment program

The Oral Health Access Fund addresses non-financial barriers to accessing oral health care faced by various segments of the Canadian population who experience difficulty accessing care. It also aims to improve access to preventative oral health services and programming. Budget 2023 announced $250 million over 3 years, starting in 2025-26, and $75 million ongoing to establish the Fund.

Expected results

Expected results include improved access to oral health services for target populations, as well as improved capacity among oral health providers to provide these services. A call-for-proposal will be launched in 2024-25 with the goal of providing funding to successful recipients beginning in 2025-26.

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan.

General targeted recipient groups

Eligible recipients include oral health training institutions, other levels of government (provincial, territorial, municipal governments, and their agencies), not-for-profit/for-profit organizations and oral health stakeholders.

Initiatives to engage applicants and recipients

Health Canada will engage applicants and recipients through different means such as workshops, bilateral discussions, correspondence, and knowledge transfer activities. Health Canada will monitor the recipients' compliance with the funding agreements, performance and results through the analysis and follow-up of regular progress, performance, and financial reporting.

Organs, Tissues, and Blood Program

Start date

April 1, 2000

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

• Program 1: Responsive Health Care Systems
• Program 3: Quality Health Science, Data and Evidence

Purpose and objectives of transfer payment program

The Organs, Tissues, and Blood Program provides support for safe, effective, accessible, and responsive organ, tissue and blood systems that will improve and extend the quality of the lives of Canadians while respecting federal, provincial, and territorial scopes of authority. Health Canada provides $5 million annually to Canadian Blood Services (CBS) (since 2000) to support research and development to improve the safety and supply of the Canadian blood system. Health Canada also provides $3.58 million annually to CBS (since 2008) to support the development and dissemination of leading practices and professional/public education materials as they relate to organ and tissue donation and transplantation. CBS is the sole recipient of the Program funding.

Expected results

With the support of the Organs, Tissues and Blood Program, CBS is expected to generate numerous knowledge products and learning events and to play a role in public education, engagement, and awareness. It also plays a significant role in training highly qualified people in important areas such as basic and applied research. CBS develops collaborative arrangements, establishes partnerships, and identifies and responds to emerging issues related to organ, tissue, and blood systems, in collaboration with the provinces and territories as appropriate.

Various stakeholders, including Health Canada, use the knowledge generated by blood research and development projects and organ donation and transplantation projects to inform changes to practices and standards. This will contribute to greater safety, effectiveness, accessibility and responsiveness of the organ, tissue and blood systems to improve and extend the quality of lives of Canadians.

Organ and tissue donation and transplantation

This Program is expected to continue to support CBS to work with partners and stakeholders to influence and improve system performance through development and dissemination of leading practices, professional and public education, engagement, and awareness materials. CBS is a member of the Organ Donation and Transplantation Collaborative and will continue to focus on the priorities identified by the Collaborative to improve organ and tissue donation and transplantation.

Blood research and development

In this context, "blood" includes whole blood and blood products, plasma and plasma products and their respective artificial and substitute products.

With support from the Program, CBS helps maintain and increase the safety, supply, and efficiency of the Canadian blood system by advancing innovation and maintaining Canadian capacity in transfusion science and medicine. In 2024-25, CBS is expected to continue to foster research, facilitate dissemination and application of knowledge, educate the next generation of scientific and health care experts, and engage with an interdisciplinary network of partners in Canada and beyond.

Fiscal year of last completed evaluation

2022-23

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2027-28

General targeted recipient groups

Canada Blood Services is the sole recipient.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with Canadian Blood Services' staff and senior management to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

The Shared Health Priorities Initiative^{Footnote 1}

Start date

November 9, 2017

End date

March 31, 2033

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2022-23

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 1: Canada has modern and sustainable health care systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

Through new investments outlined in Budget 2023 associated with the Working Together to Improve Health Care for Canadians Plan, this Program was expanded to support provinces and territories in addressing the following shared health priorities:

• Expanding access to family health services, including in rural and remote areas.
• Supporting health workers and reducing backlogs for health services such as surgeries and diagnostics.
• Improving access to quality mental health, substance use, and addictions services.
• Modernizing the health care system with standardized information and digital tools so health care providers and patients have access to electronic health information.
• Helping Canadians age with dignity, closer to home, by supporting efforts to improve access to home and community care, and safe long-term care.

The Plan includes $25 billion over 10 years (2023-24 to 2032-33) in bilateral funding to support the first 4 shared health priorities, which will be transferred to provinces and territories through the Working Together agreements. These agreements also include the remaining $2.4 billion of $5 billion from Budget 2017 to improve access to mental health and addictions services by supporting one or more of the areas of action outlined in the August 2017 Common Statement of Principles on Shared Health Priorities.

Health Canada will also provide provinces and territories with $3 billion over 5 years through Aging with Dignity agreements to support them in helping Canadians age with dignity close to home. Provinces and territories will:

• Apply standards of care in long-term care facilities.
• Help support workforce stability, including wage top-ups and improvements to workplace conditions.

The Aging with Dignity agreements also include the remaining $2.4 billion from the Budget 2017 commitment of $6 billion over 10 years to advance the priorities associated with home and community care in the Common Statement of Principles on Shared Health Priorities.

Expected results

It is expected that through these investments, Canadians will experience tangible improvements in access to high-quality family health services (i.e., family doctor, or nurse practitioner); timely, equitable, and high-quality mental health and substance use services, with a focus on youth; interoperable digital tools and data; home and community care, and palliative care services. Canadians will also receive improved long-term care by ensuring consistent standards are applied, strengthening enforcement and oversight, and supporting initiatives to enhance workforce stability.

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

Not applicable.

General targeted recipient groups

Provinces and territories.

Initiatives to engage applicants and recipients

Health Canada officials will engage regularly with provinces and territories to discuss progress. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance, and results through the analysis and follow-up of progress, performance and financial reporting.

Substance Use and Addictions Program

Start date

December 4, 2014

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2018-19

Link to the departmental results

• Core Responsibility 2: Health Protection and Promotion
  • Result 4: Canadians are protected from unsafe consumer and commercial products and substances

Link to the department's Program inventory

• Program 15: Tobacco Control
• Program 16: Controlled Substances
• Program 17: Cannabis

Purpose and objectives of transfer payment program

The Substance Use and Addictions Program (SUAP) provides funding for a wide range of evidence-informed and innovative substance use prevention, harm reduction and treatment initiatives across Canada at the community, regional and national levels. These public education, capacity building, research, best practices/standards and service delivery initiatives target a range of substances, including opioids, stimulants, cannabis, alcohol, tobacco and vaping products.

Expected results

Health Canada provides contribution funding through SUAP in support of the Canadian Drug and Substance Strategy, as well as the delivery of 3 of the Department's Programs: Tobacco Control, Controlled Substances, and Cannabis.

In addition to funding many community, regional and national organizations, Health Canada also provides approximately $10 million SUAP funding annually to the Canadian Centre on Substance Use and Addiction to achieve national impact through partnerships, and for knowledge mobilization, capacity building and training for targeted groups/populations in the areas of stigma reduction, workforce competencies, alcohol, cannabis, and the intersections between substance use and mental health.

It is expected that through these investments, Canadians and stakeholders will have access to evidence- based information on substance use and increased availability of harm reduction and treatment services. In the longer-term, this will lead to improved knowledge and skills and will help Canadians make informed decisions about their health to reduce risk-taking behavior. These investments may contribute to reduced negative health impacts experienced by people who use drugs.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

• 2025-26 – Health Portfolio's Tobacco and Vaping Activities
• 2027-28 – Legalization and Regulation of Cannabis
• 2028-29 – Canadian Drugs and Substances Strategy

General Targeted Recipient Groups

Community-based, Indigenous, regional and national non-profit organizations, including the health and education sectors; and other levels of government and their agencies.

Initiatives to engage applicants and recipients

SUAP applicants and recipients include not-for-profit organizations, provinces, territories, municipalities, Indigenous organizations, people with lived and living experience of substance use, universities, and many other groups. The respective groups are engaged through various methods, including stakeholder outreach, solicitation processes, project development discussions, and performance reporting and monitoring tools, processes, and activities.

Health Canada will engage SUAP applicants on funding applications and work closely with successful organizations to shape their initiatives, monitor contribution agreements and obtain required performance measurement and evaluation reports. Of note, Health Canada also supports knowledge mobilization and exchange opportunities between SUAP projects and other partners and stakeholders.

Health Canada officials will continue to undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with SUAP recipient groups to discuss progress and share information. In addition, Health Canada will continue to monitor the recipient's compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Territorial Health Investment Fund

Start date

April 1, 2014

End date

March 31, 2033

Type of transfer payment

Grant

Type of appropriation

Estimates

Fiscal year for terms and conditions

2023-24

Link to the departmental result(s)

• Core Responsibility 1: Health Care Systems
  • Result 2: Canadians have access to appropriate and effective health services

Link to the department's Program inventory

Program 1: Responsive Health Care Systems

Purpose and objectives of transfer payment program

Building on an initial investment of $70 million in contribution funding (2014-15 to 2017-18), the Territorial Health Investment Fund (THIF) was renewed as a grant program in 2017-18 with an additional $108 million over 4 years (2017-18 to 2020-21) and then extended in 2021-22 with an additional $54 million over 2 years. Budget 2023 provided a total of $350 million over 10 years, starting in 2023-24, to support a 10-year renewal of the THIF. Of this funding, the Northwest Territories and Yukon were each allocated $100 million ($10 million/year), and Nunavut was allocated $150 million ($15 million/year). This funding will enable each territory to continue pursuing innovative activities in support of strong, sustainable health systems, and to offset costs associated with medical travel to support Northerners' access to the health care they need.

Expected results

The THIF supports territorial efforts to innovate and transform their health care systems and ensure Northerners have access to the health care they need. The expected results for residents in the territories include improved access to health care services; health care needs being met; and improved health status.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Continuation

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Territories.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with territories to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the grant agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Transfer payment programs with total planned spending of less than $5 million

Chemicals Management Plan Engagement and Outreach Contribution Program

Start date

April 1, 2022

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2021-22

Link to the departmental result(s)

• Core Responsibility 2: Health Protection and Promotion
  • Result 4: Canadians are protected from unsafe consumer and commercial products and substances

Link to the department's Program inventory

Program 12: Health Impacts of Chemicals

Purpose and objectives of transfer payment program

The purpose of this Program is to support the capacity of people in Canada, with an emphasis on populations who may be disproportionately impacted and Indigenous Peoples, to engage in the Chemicals Management Plan (CMP) and environmental health programs, allowing for a broad range of expertise and opinions to be heard and considered.

Expected results

The expected result is:

• People in Canada have improved capacity to participate in the implementation of the CMP and broader environmental health initiatives.

This expected result will be measured by the following indicator:

• Evidence of how contribution funding supported engagement in the CMP and/or other environmental health programs, including a description of the engagement activities completed as a result of the contribution funding.

Fiscal year of last completed evaluation

2023-24

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

2028-29

General targeted recipient groups

For-profit organizations; not-for-profit organizations and charities; academia and public institutions; Indigenous recipients; government; individuals; health service organizations, including Indigenous health organizations and community health centres.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with recipient groups to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting, both formally and informally, and solicit input on engagement activities at key points in the process. Applicant and recipient consultations will be structured to support the design of projects that will maximize reach and impact. Health Canada will also provide expertise and support throughout project delivery and performance measurement of results achieved, including engagement in the form of partnerships for outreach activities.

Climate Change and Health Capacity Building Program

Start date

April 1, 2018

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2017-18 (updated in 2023-24)

Link to the departmental result(s)

• Core Responsibility 2: Health Protection and Promotion
  • Result 4: Canadians are protected from unsafe consumer and commercial products and substances
  • Result 5: Canadians make healthy choices

Link to the department's Program inventory

Program 10: Climate Change

Purpose and objectives of transfer payment program

The purpose of the Program is to support efforts to build climate-resilient and low-carbon health systems and protect and improve the health of people living in Canada in a changing climate, including from extreme heat, through better understanding of risks and successful adaptation options, and building capacity to address and implement them.

The objectives of the Program include:

• Support actions to assess climate-related health risks and issues facing people in Canada and to implement adaptation measures to address them.
• Support efforts to build climate-resilient and low-carbon health systems.
• Support efforts to understand and address the health impacts of extreme heat.

Expected results

The expected result is:

• Funded health system actors and other relevant sectors take action to reduce the health effects of climate change.

This expected result will be measured by:

Percentage of funded health system actors that have taken evidence-based adaptation measures to reduce the health effects of climate change.

Target: 100% by March 2028

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

2025-26

General targeted recipient groups

Not-for-profit organizations; academia and public institutions; Indigenous recipients; government; international; for-profit organizations; and others such as professional associations and social services organizations.

Initiatives to engage applicants and recipients

Health Canada officials will undertake appropriate communication (for example, meetings, phone calls, e-mails, and knowledge transfer activities) with recipients to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Environmental Health Research Contribution Program

Start date

April 1, 2023

End date

March 31, 2027

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2022-23

Link to the departmental result(s)

• Core Responsibility 2: Health Protection and Promotion
  • Result 4: Canadians are protected from unsafe consumer and commercial products and substances

Link to the department's Program inventory

Program 12: Health Impacts of Chemicals

Purpose and objectives of transfer payment program

The purpose of this Program is to build external capacity and research infrastructure by funding research activities on environmental pollutants, including microplastics, in order to improve the health and quality of life of people in Canada.

Expected results

The expected results are:

• Research results are available to inform decision-making on the potential human health impacts of environmental pollutants.

These expected results will be measured by the following indicator:

Percentage of implicated federal decision-makers who indicate that they have more information available for consideration in evidence-based decision making related to impacts to human health or the environment from plastic pollution including microplastics (contribution program research).

Target: 70% by March 31, 2028

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

2026-27

General targeted recipient groups

Not-for-profit organizations; academia and public institutions; government; and professional associations.

Initiatives to engage applicants and recipients

Health Canada officials will undertake appropriate communication (for example, meetings, phone calls, e-mails, and knowledge transfer activities) with recipients to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.

Radon Outreach Contribution Program

Start date

April 1, 2018

End date

Ongoing

Type of transfer payment

Contribution

Type of appropriation

Estimates

Fiscal year for terms and conditions

2018-19

Link to the departmental result(s)

• Core Responsibility 2: Health Protection and Promotion
  • Result 4: Canadians are protected from unsafe consumer and commercial products and substances
  • Result 5: Canadians make healthy choices

Link to the department's Program inventory

Program 18: Radiation Protection

Purpose and objectives of transfer payment program

The purpose of the Radon Outreach Contribution Program is to protect and improve human health and well-being in Canada from the impacts of indoor radon exposure, by aiding in the education of people in Canada about the importance of testing their homes, schools and workplaces for radon and reducing radon levels where necessary.

Expected results

The expected results are:

• Stakeholders and people in Canada are aware of strategies and tools to reduce exposure to radon.
• Stakeholders and people in Canada are enabled to manage risk from exposure to radiation.

These expected results will be measured by the following indicators:

Percentage of people in Canada surveyed who are knowledgeable about radon.

Target: At least 70% by March 31, 2025

Percentage of households in Canada surveyed who have tested their homes for radon.

Target: 10% by March 31, 2026

Fiscal year of last completed evaluation

Not applicable.

Decision following the results of last evaluation

Not applicable.

Fiscal year of next planned evaluation

2024-25

General targeted recipient groups

Not-for-profit organizations and charities; academia and public institutions; Indigenous recipients; government; and professional associations.

Initiatives to engage applicants and recipients

Health Canada officials will undertake numerous exchanges (meetings, phone calls, e-mails, and knowledge transfer activities) with recipient groups to discuss progress. In addition, Health Canada will continue to monitor the recipients' compliance with the contribution agreement, performance and results through the analysis and follow-up of progress, performance, and financial reporting.